Maharashtra Health Minister Rajesh Tope said the is receiving 50,000 vials of Remdesivir daily
Supply of Remdesivir is short although 36,000 vials have been procured in Mumbai said BMC Commissioner Iqbal Singh Chahal
As India witnesses a surge in Covid-19 cases, Remdesivir - a key drug in the treatment of Covid-19 positive patients - is facing a supply chain bottleneck. States like Maharashtra, Karnataka, Punjab which are clocking in a high number of cases everyday are facing uneven supply of Remdesivir vials. But what exactly is causing this mismatch in supply and demand at a time when the situation is dire?
Rajiv Singhal, General Secretary of the All India Organization of Chemists and Druggists (AIOCD) said, As cases dropped in the beginning of the year, the demand for Remdesivir was low. Hence companies started slow manufacturing or manufactured in batches. Companies ramped up manufacturing after March 10 when cases started to surge. But from what we are picking up from the
Last January, Amazon founder and Chief Executive Jeff Bezos was in India, holding closed-door meetings with top industry leaders including Mukesh Ambani and Kishore Biyani. He hobnobbed with Bollywood stars, visited the iconic Taj Mahal, flew kites with children and also experienced Indian street food. He even delivered a package to a customer from a kirana store in Mumbai and shared the picture on his Instagram account. A lot has changed since then. In a surprise move, Bezos stepped down as CEO of the e-commerce giant on Tuesday. He would transition to the executive chair of Amazon Board and will stay engaged in important Amazon initiatives. Andy Jassy, who heads the company’s cloud computing platform Amazon Web Services (AWS), is expected to take over the role of CEO in the third quarter of 2021.
Chemists facing problem of plenty as demand for antiviral drugs falls
Updated:
Updated:
Share Article
Stocks of Remdesivir have a short shelf life of three months.
| Photo Credit:
File Photo Following a decline in COVID-19 cases in the country, chemists who had stocked up on antiviral drugs Remdesivir and Favipiravir used in the treatment of moderate and severe cases of the disease are facing a problem of plenty.
With the stocks having a short shelf life of three months, most of the products are nearing expiry. As the chemists had procured these drugs on advance payments, they are worried of suffering losses, with pharma companies not accepting the stocks back.
Chemists across India go on strike to oppose stringent regulations on the sale of medicines
Chemists across India go on strike to oppose stringent regulations on the sale of medicines
Chemists Across The Country Have Shut Shops In Protest Against The âstringent Regulations On The Sale Of Medicines. PTI | Updated on: 30 May 2017, 11:53:27 AM
New Delhi:
Chemists across the country have shut shops in protest against the “stringent” regulations on the sale of medicines.
According to the All India Organisation of Chemists and Druggists (AIOCD), their several representations opposing the regulations on the sale of medicines in the country, submitted to the government, went unheeded, following which the one-day strike was called.